The European and Developing Countries Clinical Trials Partnership (EDCTP) is offering a total of €5 million in grants for projects contributing to the integration and co-ordination of research carried out by EDCTP member states and their African partners in the target areas of HIV/AIDS, malaria and tuberculosis.

The grants are intended to top up already available funds for projects geared to the integration of member states’ national programmes, stronger north-south partnership, co-ordination and networking of clinical researchers, and the creation of sustainable capacity building in sub-Saharan Africa.

The EDCTP believes collaborative programmes between member states and African partners will increase the efficiency of research into the three poverty-related diseases that are the focus of the partnership, as well as providing “a powerful tool for avoiding duplication”.

Proposals lasting a maximum of three years are invited, with deadlines of 5 June and 5 December 2008 for applications. There is a ceiling of €300,000 on funds for individual proposals, except in the case of proposals involving networking activities only, where the maximum grant will be €100,000.

Funded under the European Commission’s Sixth Framework Programme for research and technological development, the EDCTP is a partnership between European and sub-Saharan countries that aims to reduce poverty by developing new clinical interventions to fight HIV/AIDS, malaria and tuberculosis.

These efforts are centred on Phase II and III clinical trials in sub-Saharan Africa. Partners include 14 European Union member states, Norway, Switzerland and 47 sub-Saharan African countries.